Does Adding Bevacizumab Therapy in Glaucoma Surgery Improve the Success of Needle Bleb Revisions?

• Status: Completed
• Trial end date: 2012-01-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to see if a new add on (or adjunctive) therapy used in glaucoma surgery improves the success of needle bleb revisions.

• Phase: Phase 2/Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Wills Eye
• Treatments: Bevacizumab; Pharmaceutical Solutions; Polystyrene sulfonic acid

Criteria

Inclusion Criteria:

• require glaucoma bleb needle revision with Mitomycin-C

Exclusion Criteria:

• pregnant, nursing, or not using adequate contraception

• other glaucoma eye surgery involving tube shunts

• prior retinal detachments surgery with scleral buckle

• infection, inflammation, or any abnormality preventing eye pressure measurement

• enrolled in another investigational study